Yahoo Finance • 3 months ago

Vertex Announces Health Canada Acceptance of New Drug Submission for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-in-Class Triple Combination Treatment for Cystic Fibrosis

TORONTO, Sept. 26, 2024 /CNW/ - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Health Canada has accepted for review its New Drug Submission (NDS) for vanzacaftor/tezacaftor/deutivacaftor, a once-daily triple combi... Full story

Yahoo Finance • 3 months ago

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

– First regulatory authorization of a CRISPR-based gene-editing therapy in Canada – TORONTO, Sept. 25, 2024 /CNW/ - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced Health Canada has granted Marketing Authorization for P... Full story

Yahoo Finance • 3 months ago

Prediction: These 3 Phenomenal Stocks Are Set to Soar

No one knows for sure how any stock will perform over the next 12 months. There are simply too many variables that can come into play. However, that doesn't mean that analysts and investors can't have pretty good hunches about what certai... Full story

Yahoo Finance • 3 months ago

Vertex Pharmaceuticals Incorporated (VRTX): Why Do Hedge Funds Recommend This Biotech Stock?

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds.In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other biotech stocks... Full story

Yahoo Finance • 4 months ago

3 No-Brainer Stocks to Buy in September

Don't want to think too hard about your investing decisions? Then go with the stocks of highly profitable companies with strong growth prospects. Three Motley Fool contributors identified several stocks that fit this description. Here's w... Full story

Yahoo Finance • 4 months ago

Vertex Pharmaceutical Inc. (VRTX): Jim Cramer’s Go-To Stock For Success

We recently compiled a list of the Jim Cramer’s 10 Go-To Stocks for Success.In this article, we are going to take a look at where Vertex Pharmaceutical Inc. (NASDAQ:VRTX) stands against Jim Cramer's other go-to stocks for success. In a re... Full story

Yahoo Finance • 4 months ago

3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever

Almost every portfolio needs a couple of anchor stocks that tend to grow consistently over time regardless of the mood of the market or the state of the economy. Thanks to the must-buy nature of lifesaving medicines and the regular launch... Full story

Yahoo Finance • 4 months ago

Vertex to Participate in Upcoming September Investor Conferences

BOSTON, August 22, 2024--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences. Dr. Reshma Kewalramani, Chief Executive Officer and President, and... Full story

Yahoo Finance • 4 months ago

3 Fantastic Growth Stocks to Buy in August

The recent stock market sell-off appears to have fizzled out and now could be a great time for long-term investors to put some of their cash to work. Three Motley Fool contributors think they've found fantastic growth stocks to buy in Aug... Full story

Yahoo Finance • 4 months ago

Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them

If hockey great Wayne Gretzky received a quarter every time his most famous quote was cited, he'd probably have more money than he made during his sports career. That quote, of course, is: "I skate to where the puck is going, not where it... Full story

Yahoo Finance • 5 months ago

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now

Few healthcare companies are more famous than Johnson & Johnson(NYSE: JNJ). The pharmaceutical giant earned its stature in the industry thanks to its incredible innovative abilities and a business that's been executing for decades. Howeve... Full story

Yahoo Finance • 5 months ago

Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday?

Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday? Wall Street is experiencing a sharp decline on the last trading day of the week, with all indices in the red at noon i... Full story

Yahoo Finance • 5 months ago

2 No-Brainer Growth Stocks to Buy With $1,000 Right Now

The stock market has had a roaring first half of 2024. As summer begins and many are planning summer vacations, planning for a better financial future should also be part of the equation. Building a portfolio that stands up to the test of... Full story

Yahoo Finance • 5 months ago

Baillie Gifford's Strategic Moves in Q2 2024: A Closer Look at NVIDIA Corp's Impact

Insight into Baillie Gifford (Trades, Portfolio)'s Latest 13F Filings and Portfolio Adjustments Warning! GuruFocus has detected 3 Warning Signs with NVDA. Baillie Gifford (Trades, Portfolio), a century-old investment management firm, rec... Full story

Yahoo Finance • 5 months ago

2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street

For more than 18 months, the bulls have ruled the roost on Wall Street. Since 2023 began, the ageless Dow Jones Industrial Average(DJINDICES: ^DJI), benchmark S&P 500(SNPINDEX: ^GSPC), and growth-centric Nasdaq Composite(NASDAQINDEX: ^IXIC... Full story

Yahoo Finance • 5 months ago

Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

Stock splits have created a lot of excitement in the market in recent times, with big name players across industries announcing such operations -- from retail giant Walmart to artificial intelligence (AI) chip leader Nvidia and popular fas... Full story

Yahoo Finance • 5 months ago

3 No-Brainer Stocks to Buy in July

July is for barbecues, fireworks, and vacations. Many people don't want to think too hard about anything. Three Fool.com contributors think they have solutions for those investors who don't want to think too hard. Here's why they picked E... Full story

Yahoo Finance • 6 months ago

Forget Eli Lilly: 3 Biotech Stocks to Buy Instead

A few years ago, Eli Lilly(NYSE: LLY) was far from the hottest stock in the biopharmaceutical world. But times have changed. Today, Lilly ranks as the biggest healthcare company in the world. It still has tremendous growth prospects with i... Full story

Yahoo Finance • 6 months ago

2 Healthcare Stocks That Are Screaming Buys in June

This latest bull market is seeing a wave of enthusiasm from investors ... for the stocks of select companies. While some stocks are getting enthusiastic buy-in, there are plenty of others that haven't quite joined in on the market frenzy.... Full story

Yahoo Finance • 6 months ago

Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions

– All 12 patients who received the full dose of VX-880 as a single infusion demonstrated islet cell engraftment and glucose-responsive insulin production by Day 90 – – All patients achieved ADA-recommended target HbA1c levels <7.0% and >7... Full story